The clinical success of CAR T-cell therapy has spurred increased interest and investments in the advanced therapeutics industry.
In an effort to standardize these therapeutics, regulatory agencies have implemented more stringent requirements, causing an evolution of manufacturing guidelines. A critical component of any therapeutic development is to ensure the manufacturing workflow incorporates equipment and reagents suitable for clinical manufacturing.
- Meet requirements for commercial manufacturing processes
- Be integrated with a range of products and tools designed for use in cell therapy manufacturing
- Optimize the cell engineering step of your manufacturing process
